Genflow Biosciences plc (LON:GENF)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1.825
0.00 (0.00%)
Nov 5, 2026, 4:08 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 10.34 million as of November 5, 2026. It is the 39,313th most valuable company in the world and the 860th biggest in the United Kingdom. Its market cap has increased by 0.94% in one year.
Market Cap
10.34M
Enterprise Value
9.70M
Revenue
585.61K
Global Rank
Country Rank
#860 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 10.34M, a decrease of -69.27%. That is a compound annual growth rate of -21.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 10.34M | 13.21% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 18.79M |
| Oxford BioDynamics | 14.79M |
| SkinBioTherapeutics | 12.96M |
| Thalia Therapeutics | 10.21M |
| Aptamer Group | 9.85M |
| Fusion Antibodies | 7.20M |
| CRISM Therapeutics | 6.93M |
| Solvonis Therapeutics | 6.81M |